Clinical Trial Update: Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of solifenacin succinate and tamsulosin hydrochloride OCAS in men with benign prostatic hyperplasia and lower urinary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Solifenacin succinate (solifenacin)
• Tamsulosin hydrochloride OCAS (tamsulosin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 3 | Status: COMPLETED | Results posted: 2015-12-17